(Q42172050)

17 October 2017

title

Diminished quality of life in patients with cancer correlates with tryptophan degradation (English)

1 reference

17 October 2017

1 reference

6

Dietmar Fuchs

1 reference

17 October 2017

Katharina Schroecksnadel

1

object named as

Katharina Schroecksnadel

1 reference

17 October 2017

Michael Fiegl

2

1 reference

17 October 2017

Karin Prassl

3

1 reference

17 October 2017

Christiana Winkler

4

1 reference

17 October 2017

Hubert A Denz

5

1 reference

17 October 2017

publication date

14 March 2007

1 reference

Journal of Cancer Research and Clinical Oncology

17 October 2017

published in

1 reference

17 October 2017

volume

133

1 reference

17 October 2017

issue

7

1 reference

17 October 2017

page(s)

477-485

1 reference

Fatigue and proinflammatory cytokine activity in breast cancer survivors

17 October 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-007-0191-3

Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-007-0191-3

Enhanced tryptophan degradation in systemic lupus erythematosus

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-007-0191-3

Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS.

21 January 2018

1 reference

12 December 2020

Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism

1 reference

12 December 2020

Weight loss in patients with hematological neoplasias is associated with immune system stimulation

1 reference

12 December 2020

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

1 reference

12 December 2020

Depression and HIV infection: impact on immune function and disease progression.

1 reference

12 December 2020

Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases

1 reference

12 December 2020

Simultaneous measurement of serum tryptophan and kynurenine by HPLC

1 reference

12 December 2020

Tryptophan degradation in patients with gynecological cancer correlates with immune activation

1 reference

12 December 2020

The role of cytokines in cancer-related fatigue

1 reference

12 December 2020

Neopterin and prognosis in patients with adenocarcinoma of the colon

1 reference

12 December 2020

Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma

1 reference

12 December 2020

Serum levels of neopterin as related to the prognosis of human prostatic carcinoma

1 reference

12 December 2020

Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite

1 reference

12 December 2020

Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix

1 reference

12 December 2020

Immune reaction links disease progression in cancer patients with depression

1 reference

12 December 2020

Predictive value of urinary neopterin in patients with lung cancer

1 reference

12 December 2020

Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment

1 reference

12 December 2020

Neopterin production, tryptophan degradation, and mental depression--what is the link?

1 reference

12 December 2020

Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms

1 reference

12 December 2020

Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression

1 reference

12 December 2020

Relation between depression and circulating immune products in patients with advanced colorectal cancer

1 reference

12 December 2020

Clinical significance of neopterin for prognosis and follow-up in ovarian cancer

1 reference

12 December 2020

Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment

1 reference

12 December 2020

Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects

1 reference

12 December 2020

Correlation between neopterin, interferon-gamma and haemoglobin in patients with haematological disorders

1 reference

12 December 2020

Neopterin is an independent prognostic variable in females with breast cancer

1 reference

12 December 2020

Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer

1 reference

12 December 2020

Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy.

1 reference

12 December 2020

Decreased serum tryptophan in patients with cancer cachexia correlates with increased serum neopterin

1 reference

12 December 2020

Molecular basis of sickness behavior

1 reference

12 December 2020

Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects

1 reference

12 December 2020

The role of C-reactive protein as a prognostic indicator in advanced cancer

1 reference

12 December 2020

Cancer cachexia and depressive states: a neuro-endocrine-immunological disease?

1 reference

12 December 2020

10.1007/S00432-007-0191-3

Identifiers

DOI

1 reference

17 October 2017

1 reference